Skip to main content
. 2023 Dec 15;15:925–951. doi: 10.2147/BCTT.S424624

Figure 7.

Figure 7

Tumor targeting by using live bacteria: live bacteria may be used to generate cascade use as a prodrug; some bacteria have synergistic effects with ROS and ROS therapy, and some immunotherapy based on bacterial antigens, chemotherapy and photothermal therapy in association with synergistic bacteria.